Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(66.7%)
Phase 4
1(33.3%)
3Total
N/A(2)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT04719741Unknown

Drug and Dose Adjustment in Preventing Postoperative Nausea and Vomiting

Role: lead

NCT01865227Not ApplicableUnknown

Obesity Surgery, Counseling, and Psychological Well-Being

Role: collaborator

NCT01079494Not ApplicableCompleted

Clinical Pharmacists Role in the Management of Hypertension in Jordan

Role: collaborator

NCT00407771Phase 4Unknown

The Effects of Tirofiban in Diabetic Patients Undergoing Elective Percutaneous Coronary Intervention

Role: lead

All 4 trials loaded